IPSEN (EPA:IPN) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
IPSEN

PRESS RELEASE

published on 01/14/2026 at 07:00, 7 months 29 days ago

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
Ipsen presents new data at TOXINS 2026 conference on post-stroke spasticity and other neurological conditions, emphasizing care solutions. 14 abstracts showcase Dysport's role

Ipsen Neurological Diseases Dysport Post-stroke Spasticity TOXINS 2026
BRIEF

published on 12/22/2025 at 07:05, 8 months 21 days ago

Ipsen Expands Pipeline with Innovative Antibody-Drug Conjugate

Oncology Ipsen Antibody-drug Conjugate Global Rights SIM0613
BRIEF

published on 12/22/2025 at 07:05, 8 months 21 days ago

Ipsen élargit son portefeuille de produits avec un conjugué anticorps-médicament innovant

Oncologie Ipsen Conjugué Anticorps-médicament Droits Mondiaux SIM0613
PRESS RELEASE

published on 12/22/2025 at 07:00, 8 months 21 days ago

Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
Ipsen expands pipeline with Simcere Zaiming's novel antibody drug conjugate SIM0613 targeting LRRC15 protein for enhanced tumor penetration and anti-tumor activity. Phase I expected in H2 2026

Ipsen Antibody Drug Conjugate SIM0613 Simcere Zaiming LRRC15
PRESS RELEASE

published on 12/22/2025 at 07:00, 8 months 21 days ago

Ipsen élargit son portefeuille de produits en développement précoce avec un conjugué anticorps-médicament innovant développé par Simcere Zaiming
Ipsen acquiert les droits mondiaux pour le développement du conjugué anticorps-médicament SIM0613 ciblant la protéine LRRC15. Lancement prévu en Phase I au second semestre 2026

Oncologie Ipsen Conjugué Anticorps-médicament SIM0613 LRRC15
BRIEF

published on 12/05/2025 at 07:03, 9 months 7 days ago

Transfert des actions Beech Tree à la Fondation Alasol par Ipsen

Transfert D'actions Ipsen Henri Beaufour Fondation Alasol Beech Tree
BRIEF

published on 12/05/2025 at 07:03, 9 months 7 days ago

Transfer of Beech Tree shares to the Alasol Foundation by Ipsen

Share Transfer Ipsen Henri Beaufour Beech Tree Alasol Foundation
PRESS RELEASE

published on 12/05/2025 at 06:58, 9 months 7 days ago

Ipsen apporte des précisions sur l'héritage d'Henri Beaufour
Ipsen apporte des précisions sur l'héritage d'Henri Beaufour. Transfert d'actions de Beech Tree à la Fondation Alasol après le décès de M. Beaufour, sans impact sur les accords actuels

Transfert D'actions Ipsen Henri Beaufour Fondation Alasol Beech Tree
PRESS RELEASE

published on 12/05/2025 at 06:58, 9 months 7 days ago

Ipsen provides update on legacy of Henri Beaufour
Ipsen provides update on the transfer of Beech Tree shares to the Alasol Foundation following the passing of Henri Beaufour, Ipsen's Board Member, to support education for disadvantaged children and young adults

Education Ipsen Henri Beaufour Alasol Foundation Beech Tree Shares
BRIEF

published on 12/01/2025 at 07:05, 9 months 11 days ago

Ipsen Announces the Passing of Henri Beaufour

Business Development Board Member Ipsen Henri Beaufour Corporate Legacy

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 29 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 4 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 59 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 39 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 4 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 34 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 49 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 54 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 19 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 49 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE